期刊文献+

顶空气相色谱法测定苯甲酸阿格列汀原料药中3种有机溶剂残留量 被引量:1

Determination of 3 Residual Organic Solvents in Alogliptin Benzoate Raw Materid by Headspace GC
原文传递
导出
摘要 目的:建立检测苯甲酸阿格列汀原料药中甲苯、正丁醇、乙醇残留量的方法。方法:采用顶空气相色谱法。采用氢火焰离子化检测器,色谱柱为6%氰丙基苯基-94%甲基聚硅氧烷毛细管柱,进样口温度为200℃,检测器温度为250℃,分流比为10∶1,流速为1 ml/min,顶空进样,进样量为20μl,程序升温;以外标法计算甲苯、正丁醇、乙醇的残留量。结果:3种有机溶剂在16 min内能完全分离,分离度均大于1.5;甲苯、正丁醇、乙醇的质量浓度分别在22.25~178、125~1 000、125~1 000μg/ml范围内与各自峰面积呈良好的线性关系(r=0.999 8、0.999 6、0.998 7);精密度试验的RSD≤1.36%;甲苯、正丁醇、乙醇的平均加样回收率分别为98.2%、101.8%、98.90%,RSD分别为0.6%、0.7%、0.9%(n均为9)。结论:该方法操作简便、结果准确,可用于苯甲酸阿格列汀原料药中有机溶剂残留量的控制。 OBJECTIVE:To establish a method for detection of toluene,N-butanol and ethannol in alogliptin benzoate raw material. METHODS:Headspace gas chromatography(GC)and flame ionization detector(FID)detector were used. The column was6% cyanopropyl phenyl-94%methyl polysiloxane capillary column,inlet temperature was 200 ℃,detector temperature was 250 ℃,split ratio was 10∶1,flow rate was 1 ml/min with headspace and temperature programmed. The injection volume was 20 μl. The the organic residual solvents(toluene,N-butanol and ethanol)were calculated by external standard method. RESULTS:Three organic solvents were completely separated within 16 min,and the separation rate was more than 1.5. The linear range were 22.25-178 μg/ml for toluene(r=0.999 8),125-1 000 μg/ml for N-butanol(r=0.999 6),125-1 000 μg/ml for ethanol(r=0.998 7). RSD of precision was lower than 1.36%. Average recovery rates were 98.2%,101.8%,98.9%(RSD were 0.6%,0.7%,0.9%,n=9). CONCLUSIONS:The method is simple and accurate. It can be used for the control of the residual solvents in alogliptin benzoate raw material.
出处 《中国药房》 CAS 北大核心 2015年第9期1269-1271,共3页 China Pharmacy
关键词 苯甲酸阿格列汀 原料药 顶空气相色谱法 有机溶剂 残留量 Alogliptin benzoate Raw material Headspace gas chromatography Organic solvent Residus
  • 相关文献

参考文献8

二级参考文献59

  • 1马义,周天鸿.胰高血糖素样肽1的研究及应用进展[J].中国组织工程研究与临床康复,2007,11(29):5806-5809. 被引量:10
  • 2Feng J,Zhang Z,Wallace MB,et al.Discovery of alogliptin:A potent,selective,bioavailabe,and efficacious inhibitor of dipeptidyl peptidase IV[J].J Med Chem,2007,50(10):2297-2300.
  • 3Serradell N,Rose E,Bolos J.Alogliptin benzoate[J].Drug Future,2008,33(1):7-12.
  • 4Feng J,Gwaltney SL,Stafford JA,et al.Dipeptidyl peptidase inhibitors:WO,2007035629[P].2006,9,15.
  • 5Scott LJ.Alogliptin:a review of its use in the management of type 2 diabetes mellitus[J].Drugs,2010,70 (15):2051-2072.
  • 6Ghatak SB,Patel DS,Shanker N,et al.Alogliptin:a novel molecule for improving glycemic control in type Ⅱ diabetes mellitus[J].Curr Diabetes Rev,2010,6 (6):410-421.
  • 7Karim A,Covington P,Christopher R,et al.Pharmacokinetics of alogliptin when administered with food,metformin,or cimetidine:a twophase,crossover study in healthy subjects[J].Int J Clin Pharmacol Ther,2010,48 (1):46-58.
  • 8Christopher R,Covington P,Davenport M,et al.Pharmacokinetics,pharmacodynamics,and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects[J].Clin Ther,2008,30 (3):513-527.
  • 9Covington P,Christopher R,Davenport M,et al.Pharmacokinetic,pharmacodynamic,and tolerability profiles of the dipeptidyl peptidase4 inhibitor alogliptin:a randomized,double-blind,placebo-controlled,multiple-dose study in adult patients with type 2 diabetes[J].Clin Ther,2008,30 (3):499-512.
  • 10Fleck P,Christopher R,Covington P,et al.Efficacy and safety of alogliptin monotherapy over 12 weeks in patients with type 2 diabetes[J].Diabetes,2008,57 (Suppl.1):143.

共引文献61

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部